Saratoga, United States
CapsoVision, Inc., headquartered in the United States and based in Silicon Valley, has carved its niche in the medical device industry since its founding in 2006. Known for its tagline, "Empowering through Innovation," the company focuses on developing cutting-edge capsule endoscopy solutions.
Their flagship product, the CapsoCam Plus®, is a trailblazer in the domain with its unique 360° field of view. This device eliminates the need for capital equipment, enhancing both clinical efficiency and patient comfort. The integration with CapsoCloud® offers a cloud-based platform for streamlined image analysis, positioning CapsoVision as a pioneer in combining hardware innovation with software sophistication.
Investors will find CapsoVision's proposition compelling, with the latest Venture Round investment in January 2022 involving Taiwan Global Angels. This signifies confidence in its growth trajectory and the potential to shape the future of non-invasive diagnostics.
